Medivate Partners LLC

Investor type

VC

Founded

2012

AUM

$80 M

Location

South Korea

$10-50 m

Investment Ticket

3-5 years

Investment Horizon

Series B

Investment Stage

Sale to strategic investor, IPO

Exit Strategy

Investor profile last updated: 06 December, 2025

Profile

Founded in 2012, Medivate is one of the first private equity firms in Korea with the expertise in value investing cross-border life sciences industry. Medivate has been raised ~$80 million capital into 5 portfolio companies which include clinical stage biotech companies and contract development manufacturing organizations (CDMOs). Medivate’s management team has proven record in life sciences industry provides competitive advantage by leveraging strategic partnership with the portfolio companies, a key to the successful investment returns.

Industry

Healthcare Services Biotechnology Medical Devices Pharmaceuticals MedTech Life Sciences

Region of investment

Asia

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
6wN3WvB9nEROtXqQ 6wN3WvB9nEROtXqQ
6wN3WvB9nEROtXqQ
avatar
6wN3WvB9nEROtXqQ 6wN3WvB9nEROtXqQ
6wN3WvB9nEROtXqQ
avatar
6wN3WvB9nEROtXqQ 6wN3WvB9nEROtXqQ
6wN3WvB9nEROtXqQ
avatar
6wN3WvB9nEROtXqQ 6wN3WvB9nEROtXqQ
6wN3WvB9nEROtXqQ
avatar
6wN3WvB9nEROtXqQ 6wN3WvB9nEROtXqQ
6wN3WvB9nEROtXqQ
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about Medivate Partners LLC

Medivate Partners LLC is located in South Korea.
Medivate Partners LLC was founded in 2012.
Medivate Partners LLC invests in companies and startups in Healthcare Services, Biotechnology, Medical Devices, Pharmaceuticals, MedTech, Life Sciences.
Medivate Partners LLC invests in companies and startups in Asia.
Medivate Partners LLC invests in companies and startups at Series B.
Medivate Partners LLC usually invests $10-50 m on average.
Medivate Partners LLC has around $80m assets under management.